BRLF1 Polyclonal Antibody, PE-Cy5 Conjugated
Product Specifications
Background
Immediate-early transcription factor that controls the initiation of viral lytic gene expression and lytic reactivation from latency. Triggers lytic replication, and initiates a cellular senescence program in epithelial cells. Upregulates human DCR3/TNFRSF6B by directly binding to its receptor.
Synonyms
Replication and transcription activator; Rta; Immediate-early protein Rta; BRLF1
Gene ID
3783727
Swiss Prot
P03209
Host
Rabbit
Cross Reactivity
Human, Virus
Immunogen
81-180/605
Target
BRLF1
Clonality
Polyclonal
Isotype
IgG
Conjugation
PE-Cy5
Source
KLH conjugated synthetic peptide derived from Epstein-Barr virus Replication and transcription activator
Applications
WB
Purification
Purified by Protein A.
Excitation Emission
488nm/670nm
Concentration
1µg/µl
Dilution
WB (WB=1:500-2000)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
3783727
Cross Reactivity Details
HHV4tp2
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
C2549-18D 50 µg
CD270, CT (Tumor Necrosis Factor Receptor Superfamily Member 14, Herpes Virus Entry Mediator A, Herpes virus Entry Mediator A, HveA, Tumor Necrosis Factor Receptor-like 2, TR2, TNFRSF14, HVEA, HVEM, UNQ329/PRO509) discontinued, see 146079
Ask
View Details 